Mar E C, Chiou J F, Cheng Y C, Huang E S
J Virol. 1985 Dec;56(3):846-51. doi: 10.1128/JVI.56.3.846-851.1985.
Human cytomegalovirus-induced DNA polymerase and cellular DNA polymerase alpha were purified by successive chromatography on DEAE-cellulose, phosphocellulose, heparin agarose, and single-stranded DNA agarose columns. The purified virus-induced DNA polymerase was resolved to consist of two polypeptides corresponding to molecular weights of 140,000 and 58,000, as analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Virus-induced DNA polymerase and cellular alpha polymerase were examined for their sensitivities to the triphosphates of 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-methyluracil (FMAUTP), -5-iodocytosine (FIACTP), and -5-methylcytosine (FMACTP). The inhibitive effects of these triphosphates on the DNA polymerases were competitive with regard to the natural substrates; thus FMAUTP competes with dTTP, and FIACTP and FMACTP compete with dCTP. The inhibition constants (Ki) for FMAUTP, FIACTP, and FMACTP of virus-induced DNA polymerase are 0.06, 0.30, and 0.47 microM, respectively. Cellular DNA polymerase alpha is much less sensitive to these inhibitors, and its Ki values for FMAUTP, FIACTP, and FMACTP are 0.45, 3.10, and 2.90 microM, respectively. In addition, human cytomegalovirus-induced DNA polymerase, but not cellular DNA polymerase alpha, can utilize these analog triphosphates as alternate substrates for their corresponding natural deoxyribonucleoside triphosphates in in vitro DNA synthesis.
人巨细胞病毒诱导的DNA聚合酶和细胞DNA聚合酶α通过在DEAE - 纤维素、磷酸纤维素、肝素琼脂糖和单链DNA琼脂糖柱上连续层析进行纯化。经十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳分析,纯化的病毒诱导DNA聚合酶被解析为由分子量分别为140,000和58,000的两种多肽组成。检测了病毒诱导的DNA聚合酶和细胞α聚合酶对1 -(2'-脱氧-2'-氟-β-D-阿拉伯呋喃糖基)-5-甲基尿嘧啶(FMAUTP)、-5-碘胞嘧啶(FIACTP)和-5-甲基胞嘧啶(FMACTP)三磷酸酯的敏感性。这些三磷酸酯对DNA聚合酶的抑制作用在天然底物方面是竞争性的;因此,FMAUTP与dTTP竞争,FIACTP和FMACTP与dCTP竞争。病毒诱导的DNA聚合酶对FMAUTP、FIACTP和FMACTP的抑制常数(Ki)分别为0.06、0.30和0.47微摩尔。细胞DNA聚合酶α对这些抑制剂的敏感性要低得多,其对FMAUTP、FIACTP和FMACTP的Ki值分别为0.45、3.10和2.90微摩尔。此外,人巨细胞病毒诱导的DNA聚合酶,而非细胞DNA聚合酶α,在体外DNA合成中可以利用这些类似三磷酸酯作为其相应天然脱氧核糖核苷三磷酸酯的替代底物。